FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034285974> ?p ?o ?g. }

• W2034285974 endingPage "151" @default.
• W2034285974 startingPage "151" @default.
• W2034285974 abstract "Immune thrombocytopenic purpura (ITP) is a relatively common autoimmune disorder in which antibodies are produced to circulating platelets. Symptoms can be mild, but for most patients the risk of severe bleeding is unacceptable and treatment is required. Glucocorticoids followed by splenectomy had been the mainstays of therapy. High dose intravenous immunoglobulin and anti-RhD therapy are available for patients with severe illness, but produce only temporary benefit. Rituximab may provide more durable responses, danazol may be underutilized, and immunosuppressants and cytotoxic agents are less often required. Recently the pathophysiology of ITP has been more clearly elucidated, particularly the importance of decreased production of platelets in most patients and the very blunted rise that occurs in serum thrombopoietin (TPO). The isolation of TPO and better understanding of its role in thrombopoiesis has led to the development of new highly effective treatments. TPO analogs had some successes in treating highly refractory ITP patients but were taken out of development due to TPO-antibody induction. Two second-generation TPO-mimetics, romiplostim and the orally available eltrombopag, have recently been licensed in some territories for the treatment of ITP. Approval of eltrombopag was based on results from Phase II and III placebo-controlled clinical trials and a long-term extension study. About 80% of patients achieve significant increases in platelet count (11% of placebo patients), with reduced bleeding and reduced use of concomitant medications; responses are often durable with no tachyphylaxis. The side effects of eltrombopag are generally mild and not worse than placebo, although there are concerns about hepatic dysfunction, and the potentials for thromboses, marrow reticulin fibrosis, rebound thrombocytopenia and cataracts. This is an important new option for highly refractory patients, and its niche in earlier treatment (and for other thrombocytopenic disorders) is yet to be defined." @default.
• W2034285974 created "2016-06-24" @default.
• W2034285974 creator A5032469598 @default.
• W2034285974 date "2009-03-01" @default.
• W2034285974 modified "2023-10-18" @default.
• W2034285974 title "Treatment of immune thrombocytopenic purpura: focus on eltrombopag" @default.
• W2034285974 cites W1561897708 @default.
• W2034285974 cites W169672925 @default.
• W2034285974 cites W1971957984 @default.
• W2034285974 cites W1974541132 @default.
• W2034285974 cites W1980002878 @default.
• W2034285974 cites W1981111597 @default.
• W2034285974 cites W1986358566 @default.
• W2034285974 cites W1991302255 @default.
• W2034285974 cites W1993960588 @default.
• W2034285974 cites W1998402062 @default.
• W2034285974 cites W1998634687 @default.
• W2034285974 cites W1999792738 @default.
• W2034285974 cites W2001812196 @default.
• W2034285974 cites W2013946336 @default.
• W2034285974 cites W2015182139 @default.
• W2034285974 cites W2017955228 @default.
• W2034285974 cites W2019852890 @default.
• W2034285974 cites W2025122282 @default.
• W2034285974 cites W2025842550 @default.
• W2034285974 cites W2029854318 @default.
• W2034285974 cites W2034931099 @default.
• W2034285974 cites W2038119256 @default.
• W2034285974 cites W2039002753 @default.
• W2034285974 cites W2041664635 @default.
• W2034285974 cites W2043204167 @default.
• W2034285974 cites W2056173679 @default.
• W2034285974 cites W2062525245 @default.
• W2034285974 cites W2071145949 @default.
• W2034285974 cites W2073189639 @default.
• W2034285974 cites W2084718852 @default.
• W2034285974 cites W2086647861 @default.
• W2034285974 cites W2089627066 @default.
• W2034285974 cites W2092982665 @default.
• W2034285974 cites W2104778351 @default.
• W2034285974 cites W2119920607 @default.
• W2034285974 cites W2121116928 @default.
• W2034285974 cites W21248159 @default.
• W2034285974 cites W2126865883 @default.
• W2034285974 cites W2145439228 @default.
• W2034285974 cites W2153674764 @default.
• W2034285974 cites W2157938748 @default.
• W2034285974 cites W2277627336 @default.
• W2034285974 cites W2414274782 @default.
• W2034285974 cites W2530161238 @default.
• W2034285974 cites W2556189120 @default.
• W2034285974 cites W2564214156 @default.
• W2034285974 cites W2567388042 @default.
• W2034285974 cites W2568409640 @default.
• W2034285974 cites W2993780843 @default.
• W2034285974 doi "https://doi.org/10.2147/btt.s3130" @default.
• W2034285974 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2726065" @default.
• W2034285974 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19707404" @default.
• W2034285974 hasPublicationYear "2009" @default.
• W2034285974 type Work @default.
• W2034285974 sameAs 2034285974 @default.
• W2034285974 citedByCount "6" @default.
• W2034285974 countsByYear W20342859742014 @default.
• W2034285974 countsByYear W20342859742015 @default.
• W2034285974 countsByYear W20342859742016 @default.
• W2034285974 countsByYear W20342859742019 @default.
• W2034285974 crossrefType "journal-article" @default.
• W2034285974 hasAuthorship W2034285974A5032469598 @default.
• W2034285974 hasBestOaLocation W20342859741 @default.
• W2034285974 hasConcept C109159458 @default.
• W2034285974 hasConcept C121332964 @default.
• W2034285974 hasConcept C126322002 @default.
• W2034285974 hasConcept C142424586 @default.
• W2034285974 hasConcept C142724271 @default.
• W2034285974 hasConcept C159654299 @default.
• W2034285974 hasConcept C203014093 @default.
• W2034285974 hasConcept C204787440 @default.
• W2034285974 hasConcept C27081682 @default.
• W2034285974 hasConcept C2776309230 @default.
• W2034285974 hasConcept C2776915898 @default.
• W2034285974 hasConcept C2776958478 @default.
• W2034285974 hasConcept C2777416354 @default.
• W2034285974 hasConcept C2777863708 @default.
• W2034285974 hasConcept C2779522080 @default.
• W2034285974 hasConcept C2779705218 @default.
• W2034285974 hasConcept C2779771385 @default.
• W2034285974 hasConcept C2780588981 @default.
• W2034285974 hasConcept C2780653079 @default.
• W2034285974 hasConcept C2780931953 @default.
• W2034285974 hasConcept C28328180 @default.
• W2034285974 hasConcept C2993327898 @default.
• W2034285974 hasConcept C54355233 @default.
• W2034285974 hasConcept C71924100 @default.
• W2034285974 hasConcept C86803240 @default.
• W2034285974 hasConcept C87355193 @default.
• W2034285974 hasConcept C89560881 @default.
• W2034285974 hasConcept C90924648 @default.
• W2034285974 hasConceptScore W2034285974C109159458 @default.

• next